Table 8.

Relative cell survivals after the nanobody treatments, in comparison with the temozolomide treatments, all after 72 h.

Nanobody	Concentration	U251MG		U87MG		NCH		Astrocytes
	(μg/mL)	Sign.	p-value	Sign.	p-value	Sign.	p-value	Sign.	p-value
Nb10	10	ns		ns		ns		****	p < 0.0001
	100	ns		ns		ns		****	p < 0.0001
Nb79	100	*	0.0106	ns		ns		****	p < 0.0001
Nb179	100	**	0.0018	ns		ns		****	p < 0.0001
Nb225	100	ns		ns		*	0.0151	ns

Data only shown for the nanobodies with significantly stronger effects than 50 μM temozolomide Significance of three samples with three replicates was calculated by one-way ANOVA.

^*p < 0.05, **p < 0.01, ****p < 0.0001, ns, not significant.

Sign., significance.